Skip to content
OpenCapital
Get started

Protagonist Therapeutics PTGX Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Vornado Realty logo
Vornado RealtyVNO
17%+7.7pp
Lamb Weston logo
Lamb WestonLW
7.2%-1.0pp
Conagra Brands logo
Conagra BrandsCAG
13.6%+4.8pp
SSR Mining logo
SSR MiningSSRM
18.7%—
MSA
Mine Safety Appliances CompanyMSA
17.4%-1.9pp
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
6%+4.4pp

Other financials

Income statement

See full
Revenue$56.4M+99.0%
Operating income-$3.6M+81.1%
Net income$3.8M+132%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$193.7M+38.7%
Total debt$9.8M-13.9%
Total equity$655.5M-4.9%
Total assets$697.5M-6.0%

Cash flow

See full
Operating cash flow-$48.9M-139%
CapEx$215.0K-60.6%
Free cash flow-$49.2M-139%

Valuation

See full
Market cap$7.26B+127%
Enterprise value$7.07B+130%
P/S98×+82.6×

Profitability

See full
Operating margin-192.4%-205pp
Net margin-154.9%-182pp
FCF margin-12,264.3%-12,527pp

Returns & leverage

See full
Return on equity-17.1%-26.1pp
Debt / equity0×0.0×
Current ratio17.8×+0.5×

Where this comes from

Calculated from Protagonist Therapeutics’s reported figures.

$9.8Mtotal debt+$655.5Mtotal stockholders equity−$193.7Mcash and equivalents=$471.54M

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Protagonist Therapeutics's invested capital?
Protagonist Therapeutics (PTGX) reported invested capital of $471.54M in Q1 2026.
How has Protagonist Therapeutics's invested capital changed year-over-year?
Protagonist Therapeutics's invested capital decreased by 15.9% year-over-year, from $560.76M to $471.54M.
What is the long-term trend for Protagonist Therapeutics's invested capital?
Over 5 years (2020 to 2025), Protagonist Therapeutics's invested capital has grown at a 24.2% compound annual growth rate (CAGR), from $168.21M to $496.64M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).